LB
Liisa Bayko Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
61.5%
Neutral
38.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $12 |
9%
upside
| 1 | +33% |
0
%
| 15 Sep ‘25 27 days ago |
|
|
|
Outperform
Maintained
| $475 |
16%
upside
| 1 | +5% |
0
%
| 11 Sep ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $515.05 |
12%
upside
| 1 | -1.9% |
0
%
| 11 Sep ‘25 1 month ago |
|
|
|
In-Line
Maintained
| $2 |
41%
downside
| 3 | – |
–
| 28 May ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $99 |
35%
upside
| 1 | +68% |
0
%
| 14 Feb ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $45 |
79%
upside
| 1 | +5.9% |
0
%
| 12 Feb ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $12 |
66%
upside
| 1 | -5.9% |
0
%
| 13 Jan ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $5 |
34%
upside
| 2 | +158% |
0
%
| 16 Dec ‘24 10 months ago |
|
|
|
In-Line
Downgraded
| $0.7000 |
355%
upside
| 1 | – |
–
| 11 Dec ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $35 |
8%
downside
| 1 | +63% |
0
%
| 30 Oct ‘24 11 months ago |
|